BMRN vs Z · P/E 40, rev $1.76B vs P/E 128, $7.32B cap
Biomarin Pharmaceutical Inc (BMRN) versus Zillow Group Inc Class C (Z) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Zillow Group Inc Class C (Z) is a internet content & information company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Z does not have a complete income-statement cache yet.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. Z currently screens at market cap $7.32B and trailing P/E 128.0.
Not investment advice. Open the BMRN and Z stock pages for the full models.
Not investment advice.